Izumi Yukitoshi, Zorumski Charles F
Department of Psychiatry and Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, Missouri
Department of Psychiatry and Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, Missouri.
J Pharmacol Exp Ther. 2015 Feb;352(2):267-73. doi: 10.1124/jpet.114.220582. Epub 2014 Nov 20.
Whereas ifenprodil has been used as a selective GluN1/GluN2B (NR1/NR2B, B-type) receptor antagonist to distinguish between GluN2B (NR2B) and GluN2A (NR2A)-containing N-methyl-d-aspartate receptors (NMDARs), TCN 201 (3-chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulphonamide) and TCN 213 [N-(cyclohexylmethyl)-2-[{5-[(phenylmethyl)amino]-1,3,4-thiadiazol-2-yl}thio]acetamide] have been found to be selective GluN1/GluN2A (NR1/NR2A, A-type) antagonists. Based on the premise that A- and B-types are major synaptic NMDARs, we examined whether inhibition of NMDAR excitatory postsynaptic potentials (EPSPs) by the TCN compounds and ifenprodil are complementary. Contrary to this prediction, inhibition of NMDAR EPSPs by the TCN compounds and ifenprodil were largely overlapping in the CA1 region of hippocampal slices from 30-day-old rats. After partial inhibition by ifenprodil, TCN compounds produced little further suppression of NMDAR EPSPs. Similarly, after partial inhibition by TCN compounds ifenprodil failed to further suppress NMDAR EPSPs. However, low micromolar d-2-amino-5-phosphonovalerate, a competitive NMDAR antagonist, which alone only partially inhibits NMDAR EPSPs, markedly suppresses residual NMDAR responses in the presence of ifenprodil or the TCNs, suggesting that low 2-amino-5-phosphonovalerate antagonizes both ifenprodil- and TCN-insensitive synaptic NMDARs. These observations can be most readily interpreted if ifenprodil and TCNs act on a similar population of synaptic NMDARs. Recent lines of evidence suggest that the majority of hippocampal synaptic NMDARs are triheteromers. If so, modulation of GluN2A, and not just GluN2B NMDARs, could dampen long-term depression (LTD). Indeed, both TCNs, like ifenprodil, blocked LTD, suggesting the involvement of ifenprodil- and TCN-sensitive NMDARs in LTD induction. However, the TCNs plus ifenprodil failed to inhibit long-term potentiation (LTP), suggesting that neither ifenprodil- nor TCN-sensitive NMDARs are essential for LTP induction.
而异环磷酰胺已被用作选择性GluN1/GluN2B(NR1/NR2B,B型)受体拮抗剂,以区分含GluN2B(NR2B)和含GluN2A(NR2A)的N-甲基-D-天冬氨酸受体(NMDARs),已发现TCN 201(3-氯-4-氟-N-[4-[[2-(苯基羰基)肼基]羰基]苄基]苯磺酰胺)和TCN 213 [N-(环己基甲基)-2-[{5-[(苄基氨基]-1,3,4-噻二唑-2-基}硫代]乙酰胺]是选择性GluN1/GluN2A(NR1/NR2A,A型)拮抗剂。基于A型和B型是主要突触NMDARs这一前提,我们研究了TCN化合物和异环磷酰胺对NMDAR兴奋性突触后电位(EPSPs)的抑制作用是否互补。与这一预测相反,在30日龄大鼠海马切片的CA1区,TCN化合物和异环磷酰胺对NMDAR EPSPs的抑制作用在很大程度上是重叠的。在异环磷酰胺部分抑制后,TCN化合物对NMDAR EPSPs几乎没有进一步的抑制作用。同样,在TCN化合物部分抑制后,异环磷酰胺也未能进一步抑制NMDAR EPSPs。然而,低微摩尔浓度的D-2-氨基-5-磷酸戊酸,一种竞争性NMDAR拮抗剂,单独使用时仅部分抑制NMDAR EPSPs,在存在异环磷酰胺或TCN时能显著抑制残余的NMDAR反应,这表明低浓度的2-氨基-5-磷酸戊酸能拮抗异环磷酰胺和TCN不敏感的突触NMDARs。如果异环磷酰胺和TCN作用于相似群体的突触NMDARs,这些观察结果最容易得到解释。最近的一系列证据表明,大多数海马突触NMDARs是三杂聚体。如果是这样,调节GluN2A,而不仅仅是GluN2B NMDARs,可能会抑制长时程抑制(LTD)。事实上,与异环磷酰胺一样,两种TCN都能阻断LTD,这表明异环磷酰胺和TCN敏感的NMDARs参与了LTD的诱导。然而,TCN加异环磷酰胺未能抑制长时程增强(LTP),这表明异环磷酰胺和TCN敏感的NMDARs对LTP的诱导都不是必需的。